- Home
- RGNX vs CVGW Comparison
RGNX vs CVGW Comparison
Compare RGNX & CVGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- CVGW
- Stock Information
- Founded
- RGNX 2008
- CVGW 1924
- Country
- RGNX United States
- CVGW United States
- Employees
- RGNX N/A
- CVGW N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- CVGW Specialty Foods
- Sector
- RGNX Health Care
- CVGW Consumer Discretionary
- Exchange
- RGNX Nasdaq
- CVGW Nasdaq
- Market Cap
- RGNX 459.1M
- CVGW 517.5M
- IPO Year
- RGNX 2015
- CVGW N/A
- Fundamental
- Price
- RGNX $9.18
- CVGW $27.15
- Analyst Decision
- RGNX Strong Buy
- CVGW Hold
- Analyst Count
- RGNX 12
- CVGW 1
- Target Price
- RGNX $36.36
- CVGW $32.00
- AVG Volume (30 Days)
- RGNX 886.8K
- CVGW 110.5K
- Earning Date
- RGNX 11-06-2024
- CVGW 01-14-2025
- Dividend Yield
- RGNX N/A
- CVGW 1.84%
- EPS Growth
- RGNX N/A
- CVGW N/A
- EPS
- RGNX N/A
- CVGW N/A
- Revenue
- RGNX $84,327,000.00
- CVGW $1,011,635,000.00
- Revenue This Year
- RGNX $7.91
- CVGW N/A
- Revenue Next Year
- RGNX $214.75
- CVGW $3.27
- P/E Ratio
- RGNX N/A
- CVGW N/A
- Revenue Growth
- RGNX N/A
- CVGW 45.46
- 52 Week Low
- RGNX $8.54
- CVGW $20.30
- 52 Week High
- RGNX $28.80
- CVGW $31.26
- Technical
- Relative Strength Index (RSI)
- RGNX 43.02
- CVGW 45.10
- Support Level
- RGNX $8.87
- CVGW $26.61
- Resistance Level
- RGNX $12.11
- CVGW $30.02
- Average True Range (ATR)
- RGNX 0.96
- CVGW 0.78
- MACD
- RGNX -0.05
- CVGW -0.11
- Stochastic Oscillator
- RGNX 17.17
- CVGW 15.84
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About CVGW Calavo Growers Inc.
Calavo Growers Inc is in the avocado industry and an expanding provider of value-added fresh food. The company distributes its products both domestically and internationally and reports its operations in two different business segments: Grown and Prepared. The Grown segment consists of fresh avocados, tomatoes, and papayas. The Prepared segment comprises all other products including fresh-cut fruits and vegetables, ready-to-eat sandwiches, wraps, salads and snacks, guacamole, and salsa sold at retail and food service as well as avocado pulp sold to food service.